BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 5989024)

  • 1. Effect of alkaline and acid phosphatases on clotting: Evidence that alkaline phosphatase enhances activation of factor IX by SF, and that acid phosphatase enhances plasmatic anti-SF.
    Iatridis PG; Ferguson JH
    Thromb Diath Haemorrh; 1966 May; 15(3):365-80. PubMed ID: 5989024
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of thorium dioxide upon blood clotting and platelets. I. In vitro studies.
    Hjort PF; McGehee WG; Rapaport SI
    Thromb Diath Haemorrh; 1966 Dec; 16(3):333-53. PubMed ID: 5996663
    [No Abstract]   [Full Text] [Related]  

  • 3. [Biochemical mechanism of blood coagulation (author's transl)].
    Maki M
    Rinsho Byori; 1981 Jan; 29(1):1-10. PubMed ID: 7289094
    [No Abstract]   [Full Text] [Related]  

  • 4. Theories of blood coagulation. Properties and interactions of blood clotting factors.
    Kazal LA
    Ann Clin Lab Sci (1971); 1971; 1(2):139-54. PubMed ID: 4949446
    [No Abstract]   [Full Text] [Related]  

  • 5. Factors IX, XI, and XII: potential therapeutic targets for anticoagulant therapy in atherothrombosis.
    Rai V; Balters MW; Agrawal DK
    Rev Cardiovasc Med; 2019 Dec; 20(4):245-253. PubMed ID: 31912715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IgE-induced blood coagulation alterations in the rabbit: consumption of coagulation factors XII, XI, and IX in vivo.
    Pinckard RN; Tanigawa C; Halonen M
    J Immunol; 1975 Aug; 115(2):525-32. PubMed ID: 50367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The modification of the prephase of coagulation with dextran 150 in vitro].
    Kuhn W; Graeff H
    Klin Wochenschr; 1965 Dec; 43(23):1281-2. PubMed ID: 5872353
    [No Abstract]   [Full Text] [Related]  

  • 8. Increased coagulation factor VIII, IX, XI and XII activities in non-alcoholic fatty liver disease.
    Kotronen A; Joutsi-Korhonen L; Sevastianova K; Bergholm R; Hakkarainen A; Pietiläinen KH; Lundbom N; Rissanen A; Lassila R; Yki-Järvinen H
    Liver Int; 2011 Feb; 31(2):176-83. PubMed ID: 21134109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intrinsic pathway of coagulation and arterial thrombosis.
    Gailani D; Renné T
    Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2507-13. PubMed ID: 17916770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of alkaline phosphatase on the fibrinolysis process].
    Andreenko GV; Chechkina LV
    Vopr Med Khim; 1971; 17(5):519-24. PubMed ID: 5123469
    [No Abstract]   [Full Text] [Related]  

  • 11. [Salicylic acid derivatives used as anticoagulants].
    Bruhn HD
    Verh Dtsch Ges Inn Med; 1971; 77():1035-7. PubMed ID: 5155959
    [No Abstract]   [Full Text] [Related]  

  • 12. Studies on the product of the reaction between activated Hageman factor (factor XII) and plasma thromboplastin antecedent (factor XI).
    Ratnoff OD
    J Lab Clin Med; 1972 Nov; 80(5):704-10. PubMed ID: 4673237
    [No Abstract]   [Full Text] [Related]  

  • 13. Activation of serum thrombotic accelerator (STA) by digitonin and saponin.
    Howell RM; Scott GB
    Thromb Diath Haemorrh; 1967 Dec; 18(3-4):375-82. PubMed ID: 5590234
    [No Abstract]   [Full Text] [Related]  

  • 14. Evidence against collagen activation of platelet-associated factor XI as a mechanism for initiating intrinsic clotting.
    Osterud B; Harper E; Rapaport SI; Lavine KK
    Scand J Haematol; 1979 Mar; 22(3):205-13. PubMed ID: 451451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factor XI and factor XII as targets for new anticoagulants.
    Weitz JI
    Thromb Res; 2016 May; 141 Suppl 2():S40-5. PubMed ID: 27207423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factor XI and XII as antithrombotic targets.
    Müller F; Gailani D; Renné T
    Curr Opin Hematol; 2011 Sep; 18(5):349-55. PubMed ID: 21730835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Protein and gene structures of the contact factors and their abnormalities].
    Fujikawa K; Asakai R
    Tanpakushitsu Kakusan Koso; 1988 Apr; 33(5):976-83. PubMed ID: 3270916
    [No Abstract]   [Full Text] [Related]  

  • 18. Proceedings: Inhibition of blood coagulation factor XI-XII by monoclonal IgM.
    Valentin IR; Rimon A; Lahav M
    Isr J Med Sci; 1975 Dec; 11(12):1392. PubMed ID: 815201
    [No Abstract]   [Full Text] [Related]  

  • 19. [Behavior of surface-sensitive coagulation factors XII and XI in intravasal coagulation].
    Müller-Berghaus G; Ehlers E; Käufer P
    Verh Dtsch Ges Inn Med; 1974; 80():1458-60. PubMed ID: 4454455
    [No Abstract]   [Full Text] [Related]  

  • 20. Naturally occurring anticoagulants: a case report.
    Ross SA
    N Z Med J; 1968 Mar; 67(430):411-3. PubMed ID: 4968117
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.